Ar­ri­vo bags $45M Se­ries B to fund ma­jor de­pres­sion late-stage test and PhII-ready pan­cre­ati­tis as­set

Last year
Financing
R&D

Lil­ly to pay up to $660M in new deal with PRISM Bi­o­Lab; Boehringer part­ners with Phe­nom­ic AI

Last year
News Briefing

Neu­ro start­up stock craters af­ter PhI­II study marred with ‘sig­nif­i­cant de­vi­a­tion’ from tri­al pro­to­col

Last year
Startups
R&D

Verve rais­es $148M via pub­lic stock of­fer­ing, pri­vate place­ment with Eli Lil­ly (cor­rect­ed)

Last year
Financing

Eli Lil­ly’s Dan Skovron­sky on oral GLP-1, ‘slow­er ramp’ for Alzheimer’s and deals on ‘un­der­ap­pre­ci­at­ed’ ...

Last year
People
R&D

FDA to make de­ci­sion about Karuna's schiz­o­phre­nia drug by next Sep­tem­ber

Last year
R&D
FDA+

Am­gen teams up with Ama­zon on AI plat­form to en­hance new Ohio man­u­fac­tur­ing site

Last year
AI
Manufacturing

Big Phar­ma unites to help boost re­new­able en­er­gy for sup­ply chains in Chi­na and In­dia

Last year
Manufacturing

Il­lu­mi­na CFO says there's out­side in­ter­est in Grail as 'outright sale' ex­plored

Last year
Deals

FDA opens re­view of CAR-T safe­ty af­ter iden­ti­fy­ing 19 cas­es of post-treat­ment blood can­cer

Last year
Pharma
Cell/Gene Tx

Har­vard schol­ars call to elim­i­nate or­phan drug ex­emp­tion in IRA to save Medicare more

Last year
Law

Bio­Marin lands three-year deal for Ger­man cov­er­age of gene ther­a­py at $900K per pa­tient

Last year
Pharma
Cell/Gene Tx

Mar­ket­ingRx roundup: Pfiz­er adds hol­i­day twist to Covid boost­er ef­fort; No­vavax signs up for sports

Last year
Pharma
Marketing

Im­muno­vant takes on ar­genx, J&J with plans to test FcRn in­hibitor in mul­ti­ple par­al­lel tri­als af­ter PhI win 

Last year
R&D

Aro rais­es $41M; Can­del’s lay­offs; Lil­ly to ex­pand its ac­cel­er­a­tor to San Diego

Last year
News Briefing

No­var­tis ex­ecs high­light progress of slim­mer pipeline af­ter San­doz spin­off

Last year
R&D
Pharma

Take­da aligns with lead­ing rare dis­ease group for calls to ac­tion around health eq­ui­ty di­ag­noses

Last year
Pharma
Marketing

Mer­ck stokes pneu­mo­coc­cal ri­val­ry with Pfiz­er, re­veal­ing up­dat­ed 21-va­lent vac­cine da­ta

Last year
R&D
Pharma

Who cares about phar­ma ESG ef­forts? Pa­tients and pa­tient groups do — and they want more, sur­vey finds

Last year
Pharma
Marketing

Novo­cure to lay off 200 work­ers, nar­row pipeline for elec­tric fields can­cer ther­a­py

Last year
People
R&D

Gro­cery ben­e­fits are a grow­ing part of Medicare Ad­van­tage plans. Here's how one start­up is mak­ing them eas­i­er to use

Last year
Health Tech

Bris­tol My­ers bets $100M on Avid­i­ty's RNA ther­a­pies for car­dio­vas­cu­lar dis­eases

Last year
Deals
R&D

Ear­ly-stage health­care star­tups are fac­ing a fund­ing cliff

Last year
Financing
Health Tech

For­mer Terns CEO Senthil Sun­daram pass­es away fol­low­ing bat­tle with can­cer

Last year
People
First page Previous page 239240241242243244245 Next page Last page
A service from the Financial Times